Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9

被引:76
作者
Demoulin, JB
Van Roost, E
Stevens, M
Groner, B
Renauld, JC
机构
[1] Univ Catholique Louvain, Ludwig Inst Canc Res, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, Expt Med Unit, B-1200 Brussels, Belgium
[3] Inst Expt Canc Res, Tumor Biol Ctr, D-79106 Freiburg, Germany
关键词
D O I
10.1074/jbc.274.36.25855
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin-9 (IL-9) activates three distinct STAT proteins: STAT1, STAT3, and STAT5. This process depends on one tyrosine of the n-9 receptor, which is necessary for proliferation, gene induction, and inhibition of apoptosis induced by glucocorticoids. By introduction of point mutations in amino acids surrounding this tyrosine, we obtained receptors that activated either STAT5 alone or both STAT1 and STAT3, thus providing us with the possibility to study the respective roles of these factors in the biological activities of IL-9. Both mutant receptors were able to prevent apoptosis, but only the mutant that activated STAT1 and STAT3 was able to support induction of granzyme A and L-selectin. In line with these results, constitutively activated STATE blocked glucocorticoid-induced apoptosis. In Ba/F3 cells, significant proliferation and pim-1 induction were observed with both STAT-restricted mutants, though proliferation was lower than with the wild-type receptor. These results suggest that survival and cell growth are redundantly controlled by multiple STAT factors, whereas differentiation gene induction is more specifically correlated with individual STAT activation by IL-9.
引用
收藏
页码:25855 / 25861
页数:7
相关论文
共 40 条
[1]   Heteromerization of the γc chain with the interleukin-9 receptor α subunit leads to STAT activation and prevention of apoptosis [J].
Bauer, JH ;
Liu, KD ;
You, Y ;
Lai, SY ;
Goldsmith, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (15) :9255-9260
[2]   Cytokine receptor-independent, constitutively active variants of STAT5 [J].
Berchtold, S ;
Moriggl, R ;
Gouilleux, F ;
Silvennoinen, O ;
Beisenherz, C ;
Pfitzner, E ;
Wissler, M ;
Stocklin, E ;
Groner, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (48) :30237-30243
[3]   TYROSINE-343 IN THE ERYTHROPOIETIN RECEPTOR POSITIVELY REGULATES ERYTHROPOIETIN-INDUCED CELL-PROLIFERATION AND STAT5 ACTIVATION [J].
DAMEN, JE ;
WAKAO, H ;
MIYAJIMA, A ;
KROSL, J ;
HUMPHRIES, RK ;
CUTLER, RL ;
KRYSTAL, G .
EMBO JOURNAL, 1995, 14 (22) :5557-5568
[4]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[5]  
Demoulin J B, 1998, Int Rev Immunol, V16, P345, DOI 10.3109/08830189809043001
[6]  
Demoulin JB, 1998, CYTOKINES CELL MOL T, V4, P243
[7]  
Demoulin JB, 1999, EUR CYTOKINE NETW, V10, P49
[8]  
Demoulin JB, 1996, MOL CELL BIOL, V16, P4710
[9]   Differential activation of acute phase response factor/STAT3 and STAT1 via the cytoplasmic domain of the interleukin 6 signal transducer gp130 .1. Definition of a novel phosphotyrosine motif mediating STAT1 activation [J].
Gerhartz, C ;
Heesel, B ;
Sasse, J ;
Hemmann, U ;
Landgraf, C ;
SchneiderMergener, J ;
Horn, F ;
Heinrich, PC ;
Graeve, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (22) :12991-12998
[10]   Molecular analysis of human interleukin-9 receptor transcripts in peripheral blood mononuclear cells - Identification of a splice variant encoding for a nonfunctional cell surface receptor [J].
Grasso, L ;
Huang, MX ;
Sullivan, CD ;
Messler, CJ ;
Kiser, MB ;
Dragwa, CR ;
Holroyd, KJ ;
Renauld, JC ;
Levitt, RC ;
Nicolaides, NC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (37) :24016-24024